相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Positive and Negative Allosteric Modulators of N-Methyl-D-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action
Erica S. Burnell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Chromodomain Y-like Protein-Mediated Histone Crotonylation Regulates Stress-Induced Depressive Behaviors
Yongqing Liu et al.
BIOLOGICAL PSYCHIATRY (2019)
Neural basis of major depressive disorder: Beyond monoamine hypothesis
Shuken Boku et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Astrocytes in primary cultures express serine racemase, synthesize D-serine and acquire A1 reactive astrocyte features
Suyan Li et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
P. Molero et al.
CNS DRUGS (2018)
An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups
Riley Perszyk et al.
ELIFE (2018)
Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics
Xudong Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile
Elisia Villemure et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Mechanism and properties of positive allosteric modulation of N-methyl-D-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives
Kiran Sapkota et al.
NEUROPHARMACOLOGY (2017)
Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor-targeting atypical antipsychotics
Xudong Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Ketamine's antidepressant action: beyond NMDA receptor inhibition
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design
Matthew Volgraf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function
David H. Hackos et al.
NEURON (2016)
Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
Sheldon Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2015)
GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists
Joseph R. Moskal et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Crystal structure of a heterotetrameric NMDA receptor ion channel
Erkan Karakas et al.
SCIENCE (2014)
Structural Determinants and Mechanism of Action of a GluN2C-selective NMDA Receptor Positive Allosteric Modulator
Alpa Khatri et al.
MOLECULAR PHARMACOLOGY (2014)
Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics
Yin Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors
Steven M. Paul et al.
JOURNAL OF NEUROSCIENCE (2013)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
The NMDA receptor as a target for cognitive enhancement
Graham L. Collingridge et al.
NEUROPHARMACOLOGY (2013)
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
Daniel T. Monaghan et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines
Laetitia Mony et al.
EMBO JOURNAL (2011)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors
Blaise Mathias Costa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
A subunit-selective potentiator of NR2C-and NR2D-containing NMDA receptors
Praseeda Mullasseril et al.
NATURE COMMUNICATIONS (2010)
A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus
Xiao-lei Zhang et al.
NEUROPHARMACOLOGY (2008)
Rules of engagement for NMDA receptor subunits
Maximilian H. Ulbrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors
Elena Kartvelishvily et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate
M Horak et al.
NEUROSCIENCE (2006)
GLYX-13:: A monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator
JR Moskal et al.
NEUROPHARMACOLOGY (2005)
Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids
A Malayev et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors
JR Moskal et al.
CURRENT DRUG TARGETS (2001)